During the past decade, East and North Hertfordshire NHS Trust conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East and North Hertfordshire NHS Trust" #1 sponsor was "East and North Hertfordshire NHS Trust" with 7 trials, followed by "Pfizer" with 5 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "University of Leeds" with 2 trials sponsored and "BeiGene" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East and North Hertfordshire NHS Trust" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "University of Hertfordshire" with 2 trials as a collaborator, "University of Oxford" with 2 trials as a collaborator and "Addenbrookes Charitable Trust" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "East and North Hertfordshire NHS Trust" are "Prostate Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Giant Cell Arteritis" (2 trials), "Melanoma (Skin)" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "East and North Hertfordshire NHS Trust" in a lesser frequency.

Most popular intervention types in "East and North Hertfordshire NHS Trust" are "Drug" (15 trials), "Biological" (4 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Docetaxel" (2 trials), "Enzalutamide" (2 trials), "Selatogrel" (2 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "East and North Hertfordshire NHS Trust" are 19 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "East and North Hertfordshire NHS Trust". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in East and North Hertfordshire NHS Trust, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in East and North Hertfordshire NHS Trust, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

East and North Hertfordshire NHS Trust has several departments that took part in Clinical trials: "Mount Vernon Cancer Centre at Mount Vernon Hospital" - 123 trials